TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 4 | -2 | -9 | -4 | 0 | -13 | -11 | -6 |
S | %wins | 100 | 100 | 75 | 50 | 75 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/23/18 17:48 | 3/21/18 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Maniatis Tom | MA | D | M.d | 95 | 5.08 | 0 | 19 | 16 | 135 | D | |||||||||||||||
12/9/14 17:26 | 12/8/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Maniatis Tom | MA | D | S | -1,053 | 45.00 | 11 | -23 | -17 | 114 | D | 64 | 27 | 73 | 23 | 29 | 11 | 19 | 0 | -13 | -5 | -6 | -28 | -4 | ||
11/4/14 17:32 | 10/31/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Maniatis Tom | MA | D | S | -936 | 40.00 | 7 | -23 | -15 | 138 | D | 61 | 10 | 15 | 21 | 17 | 7 | -2 | -4 | -7 | 4 | 8 | -18 | -4 | ||
10/28/14 18:17 | 10/27/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Maniatis Tom | MA | D | S.m | -819 | 35.00 | 7 | -23 | -13 | 161 | D | 52 | 3 | 20 | 38 | 19 | 20 | 20 | -3 | -5 | 0 | 10 | -17 | -25 | ||
7/2/14 18:50 | 6/30/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Maniatis Tom | MA | D | S | -1,390 | 33.89 | 13 | -41 | -15 | 224 | D | -3 | 1 | 7 | 4 | -2 | -2 | -2 | -11 | -13 | -11 | 11 | -12 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |